{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:53:49Z","timestamp":1780970029610,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2016-ER6304-02"],"award-info":[{"award-number":["2016-ER6304-02"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiovascular Intervention Research Institute","award":["2019-CIRI001"],"award-info":[{"award-number":["2019-CIRI001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00380-020-01598-w","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T12:04:38Z","timestamp":1586347478000},"page":"1181-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention"],"prefix":"10.1007","volume":"35","author":[{"name":"other Korea Acute Myocardial Infarction Registry (KAMIR) investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyeun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-9852","authenticated-orcid":false,"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Geol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Oh","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jah Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Young","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Oh","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Ung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eung Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Seog","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"1598_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","volume":"11","author":"GN Levine","year":"2014","unstructured":"Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC Jr (2014) Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 11:597\u2013606","journal-title":"Nat Rev Cardiol"},{"key":"1598_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ahj.2008.08.031","volume":"157","author":"KH Mak","year":"2009","unstructured":"Mak KH, Bhatt DL, Shao M, Hankey GJ, Easton JD, Fox KA, Topol EJ (2009) Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) study. Am Heart J 157:658\u2013665","journal-title":"Am Heart J"},{"key":"1598_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","volume":"50","author":"AY Shen","year":"2007","unstructured":"Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W (2007) Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50:309\u2013315","journal-title":"J Am Coll Cardiol"},{"key":"1598_CR4","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1161\/CIRCULATIONAHA.108.822791","volume":"119","author":"KY Chen","year":"2009","unstructured":"Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim CJ, Yoon JH, Chung WS, Seung KB, Park SJ (2009) Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 119:3207\u20133214","journal-title":"Circulation"},{"key":"1598_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.amjcard.2007.05.032","volume":"100","author":"S-W Lee","year":"2007","unstructured":"Lee S-W, Park S-W, Kim Y-H, Yun S-C, Park D-W, Lee CW, Hong M-K, Kim H-S, Ko J-K, Park J-H (2007) Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE\u2013Long Trial). Am J Cardiol 100:1103\u20131108","journal-title":"Am J Cardiol"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jacc.2007.11.049","volume":"51","author":"S-W Lee","year":"2008","unstructured":"Lee S-W, Park S-W, Kim Y-H, Yun S-C, Park D-W, Lee CW, Hong M-K, Kim H-S, Ko J-K, Park J-H (2008) Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus: the DECLARE-DIABETES Trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients). J Am Coll Cardiol 51:1181\u20131187","journal-title":"J Am Coll Cardiol"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"J-W Suh","year":"2011","unstructured":"Suh J-W, Lee S-P, Park K-W, Lee H-Y, Kang H-J, Koo B-K, Cho Y-S, Youn T-J, Chae I-H, Choi D-J (2011) Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. J Am Coll Cardiol 57:280\u2013289","journal-title":"J Am Coll Cardiol"},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jacc.2010.10.035","volume":"57","author":"S-W Lee","year":"2011","unstructured":"Lee S-W, Park S-W, Kim Y-H, Yun S-C, Park D-W, Lee CW, Kang S-J, Park S-J, Lee J-H, Choi SW (2011) A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with long coronary lesions) trial. J Am Coll Cardiol 57:1264\u20131270","journal-title":"J Am Coll Cardiol"},{"key":"1598_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0003319712474113","volume":"64","author":"W Gao","year":"2013","unstructured":"Gao W, Zhang Q, Ge H, Guo Y, Zhou Z (2013) Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation. Angiology 64:554\u2013558","journal-title":"Angiology"},{"issue":"241\u2013248","key":"1598_CR10","first-page":"e1","volume":"167","author":"YJ Youn","year":"2014","unstructured":"Youn YJ, Lee J-W, Ahn SG, Lee S-H, Choi H, Yu CW, Hong YJ, Kwon HM, Hong M-K, Jang Y (2014) Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease. Am Heart J 167(241\u2013248):e1","journal-title":"Am Heart J"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"1598_CR12","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann F-J, Ardissino D, De Servi S, Murphy SA (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1598_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, J\u00fcni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies (2018) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39:213\u2013260","journal-title":"Eur Heart J"},{"key":"1598_CR14","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L (2016) 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 134:e123\u2013e155","journal-title":"Circulation"},{"key":"1598_CR15","doi-asserted-by":"publisher","first-page":"e14833","DOI":"10.1097\/MD.0000000000014833","volume":"98","author":"KT Ahn","year":"2019","unstructured":"Ahn KT, Seong SW, Choi UL, Jin SA, Kim JH, Lee JH, Choi SW, Jeong MH, Chae SC, Kim YJ, Kim CJ, Kim HS, Cho MC, Gwon HC, Jeong JO, Seong IW (2019) Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention. Medicine 98:e14833","journal-title":"Medicine"},{"key":"1598_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1055\/s-0038-1626697","volume":"118","author":"J Kang","year":"2018","unstructured":"Kang J, Han JK, Ahn Y, Chae SC, Kim YJ, Chae IH, Hur SH, Seong IW, Chae JK, Cho MC, Seung KB, Jeong MH, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS (2018) Third-generation P2Y12 inhibitors in East Asian acute myocardial infarction patients: a nationwide prospective multicentre study. Thromb Haemost 118:591\u2013600","journal-title":"Thromb Haemost"},{"key":"1598_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijcard.2016.04.044","volume":"215","author":"KH Park","year":"2016","unstructured":"Park KH, Jeong MH, Ahn Y, Ahn TH, Seung KB, Oh DJ, Choi DJ, Kim HS, Gwon HC, Seong IW, Hwang KK, Chae SC, Kim KB, Kim YJ, Cha KS, Oh SK, Chae JK (2016) Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health. Int J Cardiol 215:193\u2013200","journal-title":"Int J Cardiol"},{"key":"1598_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","volume":"83","author":"K Kimura","year":"2019","unstructured":"Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T (2019) JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J 83:1085\u20131196","journal-title":"Circ J"},{"key":"1598_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4070\/kcj.2018.0166","volume":"48","author":"J Kang","year":"2018","unstructured":"Kang J, Kim H-S (2018) The evolving concept of dual antiplatelet therapy after percutaneous coronary intervention: focus on unique feature of East Asian and \u201cAsian Paradox\u201d. Korean Circ J 48:537\u2013551","journal-title":"Korean Circ J"},{"key":"1598_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1253\/circj.CJ-16-0061","volume":"80","author":"JH Kim","year":"2016","unstructured":"Kim JH, Chae SC, Oh DJ, Kim HS, Kim YJ, Ahn Y, Cho MC, Kim CJ, Yoon JH, Park HY, Jeong MH, Korea Acute Myocardial Infarction-National Institutes of Health Registry Investigators (2016) Multicenter cohort study of acute myocardial infarction in Korea- interim analysis of the Korea acute myocardial infarction registry-national institutes of health registry. Circ J 80:1427\u20131436","journal-title":"Circ J"},{"key":"1598_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11886-014-0485-4","volume":"16","author":"YH Jeong","year":"2014","unstructured":"Jeong YH (2014) \u201cEast Asian paradox\u201d: challenge for the current antiplatelet strategy of \u201cone-guideline-fits-all races\u201d in acute coronary syndrome. Curr Cardiol Rep 16:485","journal-title":"Curr Cardiol Rep"},{"key":"1598_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4070\/kcj.2017.0359","volume":"48","author":"S Han","year":"2018","unstructured":"Han S, Park G-M, Kim Y-G, Park M-W, Her SH, Lee S-W, Kim Y-H (2018) Trends, characteristics, and clinical outcomes of patients undergoing percutaneous coronary intervention in Korea between 2011 and 2015. Korean Circ J 48:310\u2013321","journal-title":"Korean Circ J"},{"issue":"Suppl 2","key":"1598_CR23","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1046\/j.1463-1326.2002.0040s2s14.x","volume":"4","author":"K Schr\u00f6r","year":"2002","unstructured":"Schr\u00f6r K (2002) The pharmacology of cilostazol. Diabetes Obes Metab 4(Suppl 2):S14\u201319","journal-title":"Diabetes Obes Metab"},{"key":"1598_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","volume":"72","author":"P Gresele","year":"2011","unstructured":"Gresele P, Momi S, Falcinelli E (2011) Anti-platelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol 72:634\u2013646","journal-title":"Br J Clin Pharmacol"},{"key":"1598_CR25","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1517\/14656566.2014.948844","volume":"15","author":"E Guerra","year":"2014","unstructured":"Guerra E, Byrne RA, Kastrati A (2014) Pharmacological inhibition of coronary restenosis: systemic and local approaches. Expert Opin Pharmacother 15:2155\u20132171","journal-title":"Expert Opin Pharmacother"},{"key":"1598_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.jacc.2004.06.066","volume":"44","author":"T Inoue","year":"2004","unstructured":"Inoue T, Uchida T, Sakuma M, Imoto Y, Ozeki Y, Ozaki Y, Hikichi Y, Node K (2004) Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol 44:1408\u20131414","journal-title":"J Am Coll Cardiol"},{"key":"1598_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.atherosclerosissup.2005.09.007","volume":"6","author":"R Morishita","year":"2005","unstructured":"Morishita R (2005) A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis. Atheroscler Suppl 6:41\u201346","journal-title":"Atheroscler Suppl"},{"key":"1598_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.thromres.2015.08.018","volume":"136","author":"Y Zou","year":"2015","unstructured":"Zou Y, Hu C, Ye W, Fan L, Xu L, Zhang A (2015) Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: a meta-analysis of randomized controlled trials. Thromb Res 136:870\u2013877","journal-title":"Thromb Res"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-020-01598-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:35:08Z","timestamp":1617838508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-020-01598-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01598-w","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"8 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no financial conflicts of interest relevant to the manuscript to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}